An IAR qualifies with Series 65, or Series 7 plus Series 66, generally within two years. Good-standing CFA, ChFC, CFP, CIC, and PFS designations may support an examination waiver; continuous-registration and limited solicitor exceptions are governed by the cited rules/guidance. The firm reports the IAR through CRD and DFPI approval is required. Current initial and renewal reporting fees are $50 each.

Prelicensing education

Education requirement explanation
Qualification and any accepted alternative or waiver must match the current state rule; exam passage alone is not registration.

Background

Fingerprint / background instructions
Form U4 disclosures and regulator follow-up apply; no separate fingerprint requirement is inferred unless expressly documented.

Application

Application fee
Current initial and renewal reporting fees are $50 each.
Application channel / system
The firm reports the IAR through CRD and DFPI approval is required.
Official application reference
https://dfpi.ca.gov/regulated-industries/broker-dealers-and-investment-advisers/information-to-assist-persons-applying-for-an-investment-adviser-certificate/

Renewal & maintenance

CE hours
FINRA, state, and firm continuing-education duties depend on effective registrations and current rules.

Portability

Portability / mobility notes
Registration is firm-, function-, and jurisdiction-specific; examination validity and approval are separate.

Military / veteran / spouse

Military experience / education credit
No broad military credit is asserted unless expressly documented.

Source governance

Primary authoritative source
https://dfpi.ca.gov/regulated-industries/broker-dealers-and-investment-advisers/information-to-assist-persons-applying-for-an-investment-adviser-certificate/
Last verified date
2026-08-26
Verification status
Verified
Review / recheck date
2026-09-26

Compare education providers

Alphabetical options; compensation never determines eligibility or placement. Confirm the exact course and jurisdiction before enrolling. This directory is not exhaustive.

No currently verified published offerings match. Check official provider and regulator resources; additional options may exist.